ROCHE HOLDING AG To Go Ex-Dividend On March 28th, 2025 With 1.36297 USD Dividend Per Share

Moomoo NewsMar 10 20:35 ET

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Roche Holding AG (OtherRHHVF)

TipRanksMar 10 07:20 ET · Ratings

Weight-loss Drug Battle: Who Are the Latest Players Involved

Seeking AlphaMar 8 13:30 ET

Roche Launches Research Hub at Harvard's Enterprise Research Campus in US

MT NewswiresMar 7 01:37 ET

F. Hoffmann-La Roche Digital Transformation Analysis Report 2024: Technology Activities, Innovation Programs, Initiatives, Partnership, Investments & Acquisition Network Map - ResearchAndMarkets.com

BusinesswireMar 6 11:04 ET

Roche Pharmaceuticals in China collaborates with JD HEALTH to empower the health ecosystem for influenza prevention and control.

● Both parties will engage in long-term cooperation in the field of influenza, jointly promoting the construction of a health service ecosystem. ● The cooperation will cover key areas such as the construction of an influenza science education system, enhancement of Internet diagnosis and treatment capabilities, application of health Big Data, and establishment of multi-party dialogue platforms.

Gelonghui FinanceMar 6 02:02 ET

Genentech Gets FDA Acceptance for Its Lupus Treatment's License Application

Seeking AlphaMar 5 10:08 ET

FDA Accepts RHHBY's SNDA for Gazyva in Treating Lupus Nephritis

Zacks Mar 5 10:05 ET

Genentech's Gazyva Moves Closer to FDA Approval for Lupus Nephritis After Positive Phase III Trial

BenzingaMar 5 02:45 ET

Roche (RHHBY.US) has received FDA approval for an innovative therapy to treat acute ischemic stroke in adults.

Roche (RHHBY.US) subsidiary Genentech announced that the USA FDA has approved the launch of the thrombolytic agent TNKase (tenecteplase).

Zhitong FinanceMar 4 08:04 ET

FDA Approves Genentech's TNKase In Acute Ischemic Stroke In Adults

BenzingaMar 3 11:47 ET

Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy

BenzingaMar 3 10:12 ET

Reported Sunday, Roche's Genentech Phase III Study Finds Xolair More Effective And Safer Than Oral Immunotherapy For Food Allergies

BenzingaMar 3 02:22 ET

Roche Gets Positive EU Regulatory Opinion for Columvi

Seeking AlphaFeb 28 13:08 ET

WHO Maintains Public Health Emergency Alert on Mpox

Seeking AlphaFeb 27 11:21 ET

Berenberg Keeps Roche at Hold, Awaits Further Evidence of Pipeline Turnaround

MT NewswiresFeb 27 09:14 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)

TipRanksFeb 24 07:10 ET · Ratings

Swiss Market Index Hits All-Time High -- Market Talk

WSJFeb 24 06:24 ET

Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News

Seeking AlphaFeb 22 09:59 ET

Express News | FDA Says Semaglutide Injection Shortage Is Resolved As Of Feb 21

BenzingaFeb 21 09:22 ET